Abbott Laboratories (TSX:ABT)

Abbott Laboratories Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	299,290	282,278	252,356	259,081	305,445	239,040
Market Cap Growth	6.83%	11.86%	-2.60%	-15.18%	27.78%	19.98%
Enterprise Value	306,888	293,055	264,064	268,395	316,734	256,931
PE Ratio	15.43	14.69	33.52	27.72	34.28	41.94
PS Ratio	4.90	4.68	4.76	4.39	5.60	5.42
PB Ratio	4.19	4.10	4.92	5.19	6.70	5.68
P/TBV Ratio	10.05	10.96	31.28	55.76	-	-
P/FCF Ratio	31.06	30.89	37.77	24.53	27.91	32.77
P/OCF Ratio	23.56	22.92	26.32	19.98	22.92	23.74
EV/Sales Ratio	5.12	4.86	4.99	4.54	5.81	5.83
EV/EBITDA Ratio	18.51	19.01	19.11	16.02	19.64	22.94
EV/EBIT Ratio	26.03	27.17	27.69	21.76	27.19	36.92
EV/FCF Ratio	31.85	32.07	39.52	25.41	28.94	35.23
Debt / Equity Ratio	0.25	0.32	0.41	0.49	0.53	0.60
Debt / EBITDA Ratio	1.07	1.38	1.48	1.41	1.47	2.18
Debt / FCF Ratio	1.88	2.41	3.16	2.30	2.23	3.48
Asset Turnover	0.55	0.54	0.54	0.58	0.58	0.49
Inventory Turnover	2.84	2.92	2.81	3.37	3.56	3.22
Quick Ratio	1.09	1.05	1.00	1.06	1.28	1.14
Current Ratio	1.70	1.67	1.64	1.63	1.85	1.72
Return on Equity (ROE)	30.62%	30.91%	15.11%	19.01%	20.49%	13.91%
Return on Assets (ROA)	6.79%	6.06%	6.11%	7.61%	7.79%	4.86%
Return on Capital (ROIC)	9.03%	7.94%	8.23%	10.34%	10.64%	6.61%
Return on Capital Employed (ROCE)	12.40%	11.10%	12.20%	15.50%	14.80%	9.00%
Earnings Yield	6.48%	6.83%	3.00%	3.62%	2.93%	2.40%
FCF Yield	3.22%	3.24%	2.65%	4.08%	3.58%	3.05%
Payout Ratio	28.93%	28.62%	62.13%	47.73%	45.28%	56.95%
Buyback Yield / Dilution	0.04%	0.06%	0.85%	1.40%	-0.17%	-0.28%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.